(Q36276322)

13 August 2017

1 reference

title

Pharmacology of different progestogens: the special case of drospirenone (English)

1 reference

13 August 2017

1 reference

Sitruk-Ware R

1

1 reference

13 August 2017

publication date

1 October 2005

1 reference

13 August 2017

1 reference

13 August 2017

volume

8 Suppl 3

1 reference

13 August 2017

page(s)

4-12

1 reference

Pharmacokinetics and potency of progestins used for hormone replacement therapy and contraception

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F13697130500330382

Progestogens in hormonal replacement therapy: new molecules, risks, and benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500330382

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500330382

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500330382

Breast cancer and hormone-replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500330382

New progestogens: a review of their effects in perimenopausal and postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500330382

Pharmacological profile of progestins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500330382

Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500330382

Differentiation of the mammary gland and susceptibility to carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500330382

Progesterone receptors in reproduction: functional impact of the A and B isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500330382

Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500330382

Drospirenone, a progestogen with antimineralocorticoid properties: a short review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500330382

Progestins and cardiovascular risk markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500330382

Effect of insulin on the proliferation of cultured primate arterial smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500330382

Low-density lipoprotein receptor activity in cultured human skin fibroblasts. Mechanism of insulin-induced stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500330382

Nestorone: clinical applications for contraception and HRT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500330382

Interactions with oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500330382

The preclinical biology of a new potent and selective progestin: trimegestone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500330382

Conception and pharmacodynamic profile of drospirenone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500330382

The pharmacological profile of a novel norpregnance progestin (trimegestone).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500330382

Drospirenone: pharmacology and pharmacokinetics of a unique progestogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500330382

Nestorone: a progestin with a unique pharmacological profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500330382

Synthesis and biological activity of a new progestogen, 16-methylene-17alpha-hydroxy-18-methyl-19-norpregn-4-ene-3, 20-dione acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500330382

Estradiol and drospirenone for climacteric symptoms in postmenopausal women: a double-blind, randomized, placebo-controlled study of the safety and efficacy of three dose regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500330382

Safety and efficacy of drospirenone used in a continuous combination with 17beta-estradiol for prevention of postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500330382

Effects of progestogens on haemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500330382

Differential effects of progestins on hemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500330382

In vitro characterization of trimegestone: a new potent and selective progestin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500330382

Is the timing of withdrawal bleeding a guide to endometrial safety during sequential oestrogen-progestagen replacement therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500330382

Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500330382

10.1080/13697130500330382

21 January 2018

Identifiers

DOI

1 reference

OpenCitations bibliographic resource ID

13 August 2017

839

0 references

1 reference